Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick L Ferris

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
JAMA Ophthalmology|April 1, 2016
Quantification of Ellipsoid Zone Changes in Retinitis Pigmentosa Using en Face Spectral Domain-Optical Coherence TomographyAmir H Hariri, Hong Yang Zhang, Alexander Ho, et al.
Retina (Philadelphia, Pa.)|December 3, 2009
Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edemaFarzin Forooghian, Paul F Stetson, Scott A Meyer, et al.
Ophthalmology|January 4, 2020
Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 40Panos G Christakis, Elvira Agrón, Michael L Klein, et al.
Retina (Philadelphia, Pa.)|February 10, 2007
Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retinaSam S Dahr, Michael Cusick, Hanna Rodriguez-Coleman, et al.
American Journal of Ophthalmology|June 15, 2005
Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetesMichael Cusick, John Paul SanGiovanni, Emily Y Chew, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMAJennifer K Sun, Wesley T Beaulieu, Michele Melia, et al.
Investigative Ophthalmology & Visual Science|May 3, 2008
Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMDLynn L Huang, Hanna R Coleman, Jonghyeon Kim, et al.
Investigative Ophthalmology & Visual Science|December 20, 2014
Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trialPhilip A Petrou, Denise Cunningham, Katherine Shimel, et al.
Ophthalmology|September 18, 2003
The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up studyEmily Y Chew, Frederick L Ferris, Karl G Csaky, et al.
Investigative Ophthalmology & Visual Science|February 28, 2007
The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samplesRobert J Ross, Christine M Bojanowski, Jie Jin Wang, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
JAMA Ophthalmology|April 1, 2016
Quantification of Ellipsoid Zone Changes in Retinitis Pigmentosa Using en Face Spectral Domain-Optical Coherence TomographyAmir H Hariri, Hong Yang Zhang, Alexander Ho, et al.
Retina (Philadelphia, Pa.)|December 3, 2009
Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edemaFarzin Forooghian, Paul F Stetson, Scott A Meyer, et al.
Ophthalmology|January 4, 2020
Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 40Panos G Christakis, Elvira Agrón, Michael L Klein, et al.
Retina (Philadelphia, Pa.)|February 10, 2007
Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retinaSam S Dahr, Michael Cusick, Hanna Rodriguez-Coleman, et al.
American Journal of Ophthalmology|June 15, 2005
Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetesMichael Cusick, John Paul SanGiovanni, Emily Y Chew, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMAJennifer K Sun, Wesley T Beaulieu, Michele Melia, et al.
Investigative Ophthalmology & Visual Science|May 3, 2008
Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMDLynn L Huang, Hanna R Coleman, Jonghyeon Kim, et al.
Investigative Ophthalmology & Visual Science|December 20, 2014
Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trialPhilip A Petrou, Denise Cunningham, Katherine Shimel, et al.
Ophthalmology|September 18, 2003
The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up studyEmily Y Chew, Frederick L Ferris, Karl G Csaky, et al.
Investigative Ophthalmology & Visual Science|February 28, 2007
The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samplesRobert J Ross, Christine M Bojanowski, Jie Jin Wang, et al.
Pageof 15